Robert Lisicki, EVP, Chief Commercial Officer at ARENA PHARMACEUTICALS INC (ARNA), sold 28,600 shares at $79.35 ($2.3M) on 2021-02-02, disclosed to the SEC on 2021-02-04.
Open-market sale of $2.3M ARNA by EVP, Chief Commercial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $77.70 | 1,741 | $135K | 6.0% |
| 2 | $77.70 | 1,741 | $135K | 6.0% |
| 3 | $78.50 | 6,400 | $502K | 22.2% |
| 4 | $79.35 | 9,359 | $743K | 32.9% |
| 5 | $79.35 | 9,359 | $743K | 32.9% |
| Total | $78.96 avg | 28,600 |
| $2.3M |
| 100% |
| Filing → |
| ARNA | SELL | 2020-08-06 | $3.8M | — | Filing → |
| ARNA | SELL | 2019-11-26 | $406K | — | Filing → |